CorMedix CRMD Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '24 | TTM Q2 '24 | TTM Q1 '24 | ||
|---|---|---|---|---|---|---|
| $181.01M+11.0% | $163.06M+453% | -$46.15M+13.1% | -$53.12M-5.7% | -$50.24M-8.4% | ||
| $218.58M+32.7% | $164.66M+424% | -$50.79M+12.5% | -$58.03M-6.3% | -$54.57M-11.6% | ||
| $193.67M+29.0% | $150.14M+395% | -$50.96M+12.3% | -$58.14M-6.4% | -$54.64M-11.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is CorMedix's revenue?
- CorMedix (CRMD) generated $400.1M in revenue over the trailing twelve months, up 384.6% year over year.
- Is CorMedix profitable?
- CorMedix reported $181.0M in net income over the trailing twelve months, a 45.2% net margin.
- What are CorMedix's profit margins?
- Gross margin is 91.9% and operating margin is 48.4%, with a 45.2% net margin.
- What is CorMedix's earnings per share?
- CorMedix's diluted EPS over the trailing twelve months is $2.04.
- Where does CorMedix's income statement data come from?
- Every line is extracted from CorMedix's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
